Bispecific antibodies for drug targeting

Review of bispecific antibodies for targeted delivery of anti-cancer therapeutic agents

Hypersensitivity reactions causes by anti-PEG IgG

The mechanism by which anti-PEG antibodies can induce hypersenitivity reactions to pegylated medicines is described

ABC by anti-mPEG antibodies

Accelerated blood clearance by anti-mPEG antibodies depends on the PEG architecture

Anti-PEG antibodies before and after a first dose of Comirnaty

Covid-19 vaccines can induce anti-PEG antibodies.

PEG engager therapy

Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy

Structural basis of methoxy polyethylene glycol recognition by antibody

Targeting irinotecan liposome for pancreatic cancer treatment